Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Wednesday, April 24, 2013 12:22:34 PM
If you think that you’re safe from heart disease, America’s #1 killer, think again. There’s a good chance that you are at risk, and simply don’t know it. In fact, approximately half of all people, both men and women, who die from heart attack each year had no prior knowledge of their own heart disease. It’s the reason that researchers around the world are anxious to improve diagnostic technologies, with an eye toward saving potentially millions of lives that will otherwise be lost.
One of the newest diagnostic technologies now available for doctors in the fight against heart disease is the VentriPoint Medical System (VMSTM), going by the name “Angelo(VMSTM)”, from VentriPoint Diagnostics. Different than any other heart diagnostic system, it uses sophisticated knowledge-based reconstruction technology applied against 2D ultrasound generated data to create a clear image of the “right heart,” the portion of the heart that pumps blood to the lungs where it picks up oxygen.
It’s important for doctors to have a clear picture of right heart functioning for accurate diagnostics. However, because of the unique position of the right heart, getting a useful image has required an expensive and time-consuming MRI, especially difficult to get if the patient is a child. A standard MRI involves 1-2 hours of machine time, a radiologist, 15-45 minutes of analysis time, and often a second visit to the MRI center and a third visit back to the cardiologist. Prior to this new technology, ultrasound images of the right heart were too blurry to use, but now the VentriPoint system offers full right-heart image clarity together with the ease, speed, and cost advantages of a quick and simple ultrasound scan, usable even with babies.
Leading hospitals around the world have already begun using the VentriPoint right-heart analysis system, and the company is now in talks with 2D ultrasound OEMs to jointly build a system for the early detection of pulmonary hypertension, potentially involving thousands of machines in the U.S. alone. Additional applications of the technology are on the horizon.
For additional information, visit www.VentriPoint.com
Recent VPTDF News
- Will Shares Rise on Milestone Development for AI-Powered Heart Technology? • AllPennyStocks.com • 05/06/2024 01:50:00 PM
- Healthcare Stock Rallies Strongly Following Key Implementation • AllPennyStocks.com • 12/12/2023 06:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM